Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biodesix, Inc. - Common Stock
(NQ:
BDSX
)
8.106
+2.646 (+48.47%)
Streaming Delayed Price
Updated: 11:43 AM EST, Jan 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodesix, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session.
↗
May 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Biodesix Analysts Lower Their Forecasts After Downbeat Q1 Results
↗
May 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 14, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
May 14, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Top movers in Tuesday's after hours session
↗
May 13, 2025
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
Biodesix Announces First Quarter 2025 Results and Highlights
May 13, 2025
From
Biodesix, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 06, 2025
Via
Benzinga
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025
April 29, 2025
From
Biodesix, Inc.
Via
GlobeNewswire
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
April 23, 2025
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology
From
Biodesix, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 02, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 01, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 28, 2025
Via
Benzinga
Top movers in Tuesday's after hours session
↗
March 25, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says Expert
↗
March 04, 2025
U.S. stock futures declined on Tuesday following the worst trading day of 2025 on Monday. Futures fell in premarket trading except Nasdaq 100.
Via
Benzinga
Topics
Economy
Government
Get insights into the top gainers and losers of Monday's after-hours session.
↗
March 03, 2025
Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
March 03, 2025
From
Biodesix, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 3, 2025
↗
March 03, 2025
Via
Benzinga
Biodesix to Present at TD Cowen 45th Annual Health Care Conference
February 26, 2025
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
February 18, 2025
From
Biodesix, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
January 31, 2025
Via
Benzinga
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
January 10, 2025
Grew full-year revenue to an estimated $71.3 million, an increase of 45%
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study
January 07, 2025
Analysis of 447 patients receiving the Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal reaffirms test performance
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix Announces Third Quarter 2024 Results and Highlights
November 01, 2024
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Participate in Three Investor Conferences in November
October 29, 2024
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024
October 18, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
October 07, 2024
From
Biodesix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 04, 2024
Via
Benzinga
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
↗
October 04, 2024
Via
Benzinga
Biodesix to Present at Two Investor Conferences in September
September 05, 2024
From
Biodesix, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
